Aisha L. Siebert

Aisha L. Siebert

Auto-generated profile, based on publicly available information

Aisha L. Siebert

Rochester, NY

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CBClaudia Berrondo
Claudia Berrondo
JFJonathan Flax
Jonathan Flax
VKVictor Kucherov
Victor Kucherov
ASAisha Siebert
Aisha Siebert
TOThomas Osinski
Thomas Osinski
CBCarla J. Beckham
Carla J. Beckham
Exosomes are 30-150nM membrane-bound secreted vesicles that are readily isolated from biological fluids such as urine (UEs). Exosomes contain proteins, micro RNA (miRNA), messenger RNA (mRNA), and long non-coding RNA (lncRNA) from their cells of origin. Although miRNA, protein and lncRNA have been isolated from serum as potential biomarkers for benign and malignant disease, it is unknown if lncRNAs in UEs from urothelial bladder cancer (UBC) patients can serve as biomarkers. lncRNAs are > 200 nucleotide long transcripts that do not encode protein and play critical roles in tumor biology. As the number of recognized tumor-associated lncRNAs continues to increase, there is a parallel need to include lncRNAs into biomarker discovery and therapeutic target algorithms. The lncRNA HOX transcript antisense RNA (HOTAIR) has been shown to facilitate tumor initiation and progression and is associated with poor prognosis in several cancers. The importance of HOTAIR in cancer biology has sparked interest in using HOTAIR as a biomarker and potential therapeutic target. Here we show HOTAIR and several tumor-associated lncRNAs are enriched in UEs from UBC patients with high-grade muscle-invasive disease (HGMI pT2-pT4). Knockdown of HOTAIR in UBC cell lines reduces in vitro migration and invasion. Importantly, loss of HOTAIR expression in UBC cell lines alters expression of epithelial-to-mesenchyme transition (EMT) genes including SNAI1, TWIST1, ZEB1, ZO1, MMP1 LAMB3, and LAMC2. Finally, we used RNA-sequencing to identify four additional lncRNAs enriched in UBC patient UEs. These data, suggest that UE-derived lncRNA may potentially serve as biomarkers and therapeutic targets.

16 October 2014 in Molecular Ecology
Verified
Journal Article
Closed access
PDF file
EMEllen O. Martinson
Ellen O. Martinson
DWDavid Wheeler
David Wheeler
JWJeremy Wright
Jeremy Wright
MRMrinalini
Mrinalini
ASAisha L. Siebert
Aisha L. Siebert
JWJohn H. Werren
John H. Werren

20 July 2014 in Metabolomics
Verified
Journal Article
Closed access
PDF file
MRMrinalini
Mrinalini
ASAisha L. Siebert
Aisha L. Siebert
JWJeremy Wright
Jeremy Wright
EMEllen Martinson
Ellen Martinson
DWDavid Wheeler
David Wheeler
JWJack Werren
Jack Werren

3 June 2016 in BJU International
Verified
Journal Article
Open access
PDF file
JKJanet E. Baack Kukreja
Janet E. Baack Kukreja
MKMaureen Kiernan
Maureen Kiernan
BSBethany Schempp
Bethany Schempp
ASAisha Siebert
Aisha Siebert
AHAdriana Hontar
Adriana Hontar
EMEdward M. Messing
Edward M. Messing
Objectives: To determine if patients managed with a cystectomy enhanced recovery pathway ( CERP ) have improved quality of care after radical cystectomy ( RC ), as defined by a decrease in length of hospital stay ( LOS ) without an increase in complications or readmissions compared with those not managed with CERP . Subjects and Methods: The Quality Improvement in Cystectomy Care with Enhanced Recovery ( QUICCER ) study was a non‐randomized quasi‐experimental study. Data were collected between June 2011 and April 2015. The CERP was implemented in July 2013. The primary endpoint was LOS . Secondary endpoints were quality scores, complications and readmissions. Multivariable regression was performed. Propensity score matching was carried out to further simulate randomized clinical trial conditions. A CERP quality composite score was created and evaluated with regard to adherence to CERP elements. Results: The study included 79 patients managed with CERP and 121 who were not managed with CERP . After matching, there were 75 patients in the non‐ CERP group. The LOS was significantly different between the groups: the median LOS was 5 and 8 days for the CERP and non‐ CERP group, respectively ( P < 0.001). Multivariable linear regression showed that any complication was the most significant predictor of total LOS at 90 days after RC . The higher the quality composite score the shorter the LOS ( P < 0.001). There was no association between CERP and a greater number of complications or readmissions. Conclusions: Audited quality measures in the CERP are associated with a reduction in LOS with no increase in readmissions or complications. The CERP is important for the future improvement of peri‐operative care for RC and provides an opportunity to improve the quality of care provided.


1 November 2020 in European Urology Focus
Verified
Journal Article
Closed access
ASAisha L. Siebert
Aisha L. Siebert
LLLeiszle Lapping-Carr
Leiszle Lapping-Carr
AMAlicia K. Morgans
Alicia K. Morgans